What rockets? The SP has been on a decline for over 5 years. You're sick of hearing rants about the failures of Scott Richards? We're sick of the failures. We're also getting pretty sick of your rose tinted view of MYX that conveniently forgets the past and only looks at the past couple of months. Everyone has acknowledged the debacle that was TEVA generics purchase. What we haven't seen is Scott Richards demonstrate any ability to pivot the company into an alternative strategy. Nuvaring generic? Complete failure to get an approval. Nextstellis? So far has been underwhelming vs the expectations given to shareholders by MYX. Communication from the company? Non existent.
The only positives has been the removal of some of the rusted on members of the board (particularly Roger Corbett) and the performance of the Metrics Contract Services division.
You can bang on all you like about how wonderful the management of MYX are going but the results prove otherwise. Until that changes the criticisms remain valid and you remain wrong. We're all hopeful of better times ahead, but Scott Richards remains a major impediment to this outcome in my opinion.
MYX Price at posting:
28.5¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)